MedTrace Logo

Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients

NCT02016859 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2013-12-20

No results posted yet for this study

Summary

Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that this value may be another prognostic factor in critically ill patients such as those admitted to ICU, or those with neutropenic Fever.

The purpose of the study is to check if the IPF may be used as a prognostic Factor in these patients

Conditions

  • Critically Ill Patients
  • Neutropenic Fever Patients
  • Patients With Hip Fractures

Interventions

OTHER

Immature Platelet Fraction

Sponsors & Collaborators

  • Dr. Yishai Ofran

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-05-31
Completion
2014-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02016859 on ClinicalTrials.gov